This study uncovers an additional novel mechanism by which solamargine inhibits growth of NSCLC cells and suggests involvement of additional downstream signalling and targets of EP4 in lung cancer prevention and treatment. Here, PTGER4 is linked to non-small cell lung carcinoma.